BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 17140858)

  • 1. Neuropeptide Y receptors; antisecretory control of intestinal epithelial function.
    Cox HM
    Auton Neurosci; 2007 Apr; 133(1):76-85. PubMed ID: 17140858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The regulation of veratridine-stimulated electrogenic ion transport in mouse colon by neuropeptide Y (NPY), Y1 and Y2 receptors.
    Hyland NP; Cox HM
    Br J Pharmacol; 2005 Nov; 146(5):712-22. PubMed ID: 16100526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Y(4) receptors mediate the inhibitory responses of pancreatic polypeptide in human and mouse colon mucosa.
    Tough IR; Holliday ND; Cox HM
    J Pharmacol Exp Ther; 2006 Oct; 319(1):20-30. PubMed ID: 16807358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropeptide Y, Y1, Y2 and Y4 receptors mediate Y agonist responses in isolated human colon mucosa.
    Cox HM; Tough IR
    Br J Pharmacol; 2002 Mar; 135(6):1505-12. PubMed ID: 11906964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional consequences of neuropeptide Y Y 2 receptor knockout and Y2 antagonism in mouse and human colonic tissues.
    Hyland NP; Sjöberg F; Tough IR; Herzog H; Cox HM
    Br J Pharmacol; 2003 Jun; 139(4):863-71. PubMed ID: 12813010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PYY preference is a common characteristic of neuropeptide Y receptors expressed in human, rat, and mouse gastrointestinal epithelia.
    Holliday ND; Pollock EL; Tough IR; Cox HM
    Can J Physiol Pharmacol; 2000 Feb; 78(2):126-33. PubMed ID: 10737675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropeptide-Y and Y-receptors in the autocrine-paracrine regulation of adrenal gland under physiological and pathophysiological conditions (Review).
    Spinazzi R; Andreis PG; Nussdorfer GG
    Int J Mol Med; 2005 Jan; 15(1):3-13. PubMed ID: 15583821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide YY: a neuroendocrine neighbor of note.
    Cox HM
    Peptides; 2007 Feb; 28(2):345-51. PubMed ID: 17194503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Introduction to the reviews on neuropeptide Y.
    Gehlert DR
    Neuropeptides; 2004 Aug; 38(4):135-40. PubMed ID: 15337366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor autoradiography as mean to explore the possible functional relevance of neuropeptides: focus on new agonists and antagonists to study natriuretic peptides, neuropeptide Y and calcitonin gene-related peptides.
    Dumont Y; Chabot JG; Quirion R
    Peptides; 2004 Mar; 25(3):365-91. PubMed ID: 15134861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous peptide YY and neuropeptide Y inhibit colonic ion transport, contractility and transit differentially via Y₁ and Y₂ receptors.
    Tough IR; Forbes S; Tolhurst R; Ellis M; Herzog H; Bornstein JC; Cox HM
    Br J Pharmacol; 2011 Sep; 164(2b):471-84. PubMed ID: 21457230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NPY and Y receptors: lessons from transgenic and knockout models.
    Lin S; Boey D; Herzog H
    Neuropeptides; 2004 Aug; 38(4):189-200. PubMed ID: 15337371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cloning and characterization of rabbit neuropeptide Y receptor subtypes.
    Umeda T; Kanatani A; Iwaasa H
    Peptides; 2009 Aug; 30(8):1441-7. PubMed ID: 19481128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatic polypeptide enhances colonic muscle contraction and fecal output through neuropeptide Y Y4 receptor in mice.
    Moriya R; Fujikawa T; Ito J; Shirakura T; Hirose H; Suzuki J; Fukuroda T; Macneil DJ; Kanatani A
    Eur J Pharmacol; 2010 Feb; 627(1-3):258-64. PubMed ID: 19818748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Y1 receptor subtype mediates the cardiovascular changes evoked by NPY administered into the posterior hypothalamic nucleus of conscious rat.
    Martin JR
    Brain Res; 2004 Mar; 1002(1-2):11-20. PubMed ID: 14988028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropeptide-Y family of peptides in the autocrine-paracrine regulation of adrenocortical function.
    Nussdorfer GG; Gottardo G
    Horm Metab Res; 1998; 30(6-7):368-73. PubMed ID: 9694565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Galanin-neuropeptide Y (NPY) interactions in central cardiovascular control: involvement of the NPY Y receptor subtype.
    Díaz-Cabiale Z; Parrado C; Rivera A; de la Calle A; Agnati L; Fuxe K; Narváez JA
    Eur J Neurosci; 2006 Jul; 24(2):499-508. PubMed ID: 16903855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropeptide Y as a partial agonist of the Y1 receptor.
    Sah R; Balasubramaniam A; Parker MS; Sallee F; Parker SL
    Eur J Pharmacol; 2005 Nov; 525(1-3):60-8. PubMed ID: 16293244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Up-regulation of neuropeptide Y levels and modulation of glutamate release through neuropeptide Y receptors in the hippocampus of kainate-induced epileptic rats.
    Silva AP; Xapelli S; Pinheiro PS; Ferreira R; Lourenço J; Cristóvão A; Grouzmann E; Cavadas C; Oliveira CR; Malva JO
    J Neurochem; 2005 Apr; 93(1):163-70. PubMed ID: 15773916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of NPY receptors in the hypothalamus.
    Fetissov SO; Kopp J; Hökfelt T
    Neuropeptides; 2004 Aug; 38(4):175-88. PubMed ID: 15337370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.